China Digital Pathology Market Size & Outlook, 2023-2030
China digital pathology market, 2018-2030 (US$M)
Related Markets
China digital pathology market highlights
- The China digital pathology market generated a revenue of USD 39.5 million in 2023 and is expected to reach USD 75.5 million by 2030.
- The China market is expected to grow at a CAGR of 9.7% from 2024 to 2030.
- In terms of segment, device was the largest revenue generating product in 2023.
- Software is the most lucrative product segment registering the fastest growth during the forecast period.
Digital pathology market data book summary
| Market revenue in 2023 | USD 39.5 million |
| Market revenue in 2030 | USD 75.5 million |
| Growth rate | 9.7% (CAGR from 2023 to 2030) |
| Largest segment | Device |
| Fastest growing segment | Software |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Software, Device, Storage Systems |
| Key market players worldwide | Danaher Corp, Hamamatsu Photonics KK, Koninklijke Philips NV, Olympus Corp, Roche Holding AG ADR, McCormick & Co Inc Registered Shs Non Vtg, Inspire Medical Systems Inc, PHC Holdings Corp, Huron Consulting Group Inc, CellaVision AB Bearer Shs, IBEX Ltd, Morphic Holding Inc, Nuvation Bio Inc Ordinary Shares - Class A |
Other key industry trends
- In terms of revenue, China accounted for 3.8% of the global digital pathology market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan digital pathology market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 62.4 million by 2030.
Device was the largest segment with a revenue share of 52.15% in 2023. Horizon Databook has segmented the China digital pathology market based on software, device, storage systems covering the revenue growth of each sub-segment from 2018 to 2030.
The digital pathology market in China is anticipated to grow rapidly in coming years. Key players operating in the market are focusing to capitalize on the opportunities owing to growing patient pool and unmet medical needs in the country. For instance, in January 2014, Hamamatsu Photonics, Inc., a manufacturer of digital pathology devices, established a new facility in Beijing, China to increase the research and development activities and manufacturing capacity to address the rising unmet needs in the China market.
Moreover, strategic alliances to develop novel solutions are expected to further boost the market growth. For instance, in October 2019, Motic Easy Scan and Digital Pathology Company partnered with the British Columbia Cancer Agency for 20 years to offer telepathology consultation and automated cervical cancer screenings in China.
In August 2013, MEDITE, Inc., a manufacturer of laboratory equipment and supplies, entered into a strategic alliance with UNIC Technologies, a China-based manufacturer of digital and tele pathology solutions. As per the agreement, MEDITE would deliver advanced pathology platforms in China.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Digital Pathology Market Scope
Digital Pathology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China digital pathology market size, by product, 2018-2030 (US$M)
China Digital Pathology Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
